New pill could help men regrow hair
NCT ID NCT06724614
First seen Nov 01, 2025 · Last updated Apr 24, 2026 · Updated 21 times
Summary
This study tests an experimental oral drug called VDPHL01 for male pattern baldness (androgenetic alopecia). About 480 men aged 18 to 65 with mild to moderate hair loss will take either the drug or a placebo for 6 months, then all will receive the active drug for another 6 months. The goal is to see if the drug safely increases hair count and improves the patient's perception of hair growth.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANDROGENETIC ALOPECIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Site 01
Spokane, Washington, 99202, United States
-
Site 02
Fremont, California, 94538, United States
-
Site 03
Tampa, Florida, 33613, United States
-
Site 04
Nashville, Tennessee, 37215, United States
-
Site 05
Castle Rock, Colorado, 80109, United States
-
Site 06
New Brighton, Minnesota, 55112, United States
-
Site 07
Fountain Valley, California, 92728, United States
-
Site 08
Broomall, Pennsylvania, 19073, United States
-
Site 09
Knoxville, Tennessee, 37909, United States
-
Site 10
Plymouth Meeting, Pennsylvania, 19462, United States
-
Site 11
Columbus, Ohio, 43215, United States
-
Site 12
Metairie, Louisiana, 70006, United States
-
Site 13
Covington, Louisiana, 70433, United States
-
Site 14
Houston, Texas, 77056, United States
-
Site 15
Indianapolis, Indiana, 46250, United States
-
Site 16
Murfreesboro, Tennessee, 37130, United States
-
Site 17
Aventura, Florida, 33180, United States
-
Site 18
Hackensack, New Jersey, 07601, United States
-
Site 19
West Jordan, Utah, 84095, United States
-
Site 20
Greensville, South Carolina, 29615, United States
-
Site 21
Vista, California, 92083, United States
-
Site 22
Brighton, Massachusetts, 02135, United States
-
Site 23
Rolling Meadows, Illinois, 60008, United States
-
Site 24
Englewood, Colorado, 80111, United States
-
Site 25
Brandon, Florida, 33511, United States
-
Site 26
Clarkston, Michigan, 48346, United States
-
Site 27
West Lafayette, Indiana, 47906, United States
-
Site 28
Phoenix, Arizona, 85018, United States
-
Site 29
Lynchburg, Virginia, 24501, United States
-
Site 30
Fort Smith, Arkansas, 72916, United States
-
Site 31
Boise, Idaho, 83704, United States
-
Site 32
New Albany, Indiana, 47150, United States
-
Site 33
Seattle, Washington, 98168, United States
-
Site 34
Sherman Oaks, California, 91403, United States
-
Site 35
Rogers, Arkansas, 72758, United States
-
Site 36
Birmingham, Alabama, 35203, United States
-
Site 37
Kew Gardens, New York, 11415, United States
-
Site 38
New York, New York, 10075, United States
-
Site 39
Boardman, Ohio, 44512, United States
-
Site 40
Bellaire, Texas, 77401, United States
-
Site 41
Baton Rouge, Louisiana, 70809, United States
-
Site 42
Hollywood, Florida, 33021, United States
-
Site 43
Atlanta, Georgia, 30329, United States
-
Site 44
Dallas, Texas, 75231, United States
Conditions
Explore the condition pages connected to this study.